Morgan Adam

Track

Insider profile

Performance

Overall performance
1.9
Performance over holding periods
1.9
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 56% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Morgan Adam's trades of Heron Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
434.16
Quantity 89,140 -30.9%
Value US$3,390,032
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-12 2025-08-08
B Purchase
11,530 -26.8%
80.45
US$648,363 		11,530 -26.8% 80.45 US$648,363
2023-07-25 2023-07-21
B Purchase
54,375 -29.9%
128.37
US$1,603,654 		54,375 -29.9% 128.37 US$1,603,654
2023-05-19 2023-05-17
B Purchase
89,140 -30.9%
434.16
US$3,390,032 		89,140 -30.9% 434.16 US$3,390,032